LucidQuest’s Post

LucidQuest Views >>> How we helped a Japanese innovator in cancer Dx estimate its market size and understand the future market dynamics #Casestudies #cancertreatment Comment below! >>> lqventures.com

FYI: LucidQuest Views >>> How we helped a Japanese innovator in cancer Dx estimate its market size and understand the future market dynamics #Casestudies #cancertreatment Comment below! >>> lqventures.com

FYI: LucidQuest Views >>> How we helped a Japanese innovator in cancer Dx estimate its market size and understand the future market dynamics #Casestudies #cancertreatment Comment below! >>> lqventures.com

Last month, we were joined online by Cancer Research Horizons and LifeArc, discussing more about C-Further and what types of projects they're looking for.    🎥 Did you miss it? Watch the recording to learn about:    ✔️ the application process  ✔️ what makes a well-validated target across different modalities  ✔️ the consortiums goals & drug discovery capabilities    💡 Have a project you'd like to discuss? Watch the webinar and contact the team for any questions 👉 https://bit.ly/4eaaG8y 

Bringing about changes in the way R&D #data is organized, managed, and consumed requires patience and a real culture shift. I’m happy to have worked with such a dedicated team to support them in realizing their translational research goals with Genedata Profiler. Have a read of our latest case study with Genmab below. #EnterpriseSoftware #DigitalTransformation

A great example of how we bridge data systems at biopharmaceutical companies for augmented data science to drive #innovation in #precisionmedicine! Read the case study below and please get in touch if you’d like to discuss further. #drugdevelopment #bioinformatics #translationalmedicine

Explore how Life Science Group Ltd (LSG) is revolutionising lateral flow device technology with groundbreaking advancements in lung cancer detection using urine as a test medium. From antibody design to finished device delivery, LSG is leading the way in efficiency and accuracy. Read more about this game-changing innovation at https://lnkd.in/e37TzfNs  #LifeScienceGroup #Innovation #DiagnosticTechnology

#Lab2BIOTECH will be at #Meet2win tomorrow and this Friday. Come have a chat if any of these question resonates with you: How to develop your drug or device for #braincancers ? Does your technology match brain cancer patient's needs? What's it is your competitive advantage ? Were to find appropriate partners, #preclinical models and services? How to structure your project/company? Events planning here: https://meet2win.fr/ #DrugDevelopment #Glioblastoma

Pioneering Breakthroughs Together: A recent dialogue between Dr. Krystle Karoscik , COO of InnovoTEX Inc. . and Merom Klein from Courage Growth Partners  unveils opportunities in biotech. Learn about InnovoTEX's strategic approach to leveraging biotech advancements, setting the stage for groundbreaking progress in ovarian cancer treatments. This discussion exemplifies how our collective expertise and collaborative efforts lead to innovative solutions that change lives. #HealthcareInnovation #CollaborativeExcellence #KeiretsuForum

You know the feeling when you sign up for a service, or buy a product, and then all you hear is 🦗🦗🦗? What if instead, you don't just buy a product, but you find a partner? Listen as Elise describes the importance of partnerships in developing their tiny #bioelectronic device and how she found a team that would be invested in her long-term success ( 👋 ). Oh, and check out the groundbreaking work Opto Biosystems is doing to help those living with cancer, starting with innovating how glioblastoma is treated. #healthcareinnovation #medicaldevices #bettertogether